BioMarin Pharmaceutical Inc. buy Wedbush
Start price
05.08.25
/
50%
€53.52
Target price
05.08.26
€81.32
Performance (%)
1.61%
Price
20.02.26
€54.38
Summary
This prediction is currently active. The BUY prediction by Wedbush shows slight gains of 1.61%. This prediction currently runs until 05.08.26. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | 7.811% | 7.811% |
| iShares Core DAX® | 1.432% | 2.628% |
| iShares Nasdaq 100 | 1.892% | -0.458% |
| iShares Nikkei 225® | -1.619% | 11.097% |
| iShares S&P 500 | 1.921% | 1.159% |
Comments by Wedbush for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $94.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Wedbush for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€46.07
28.10.25
28.10.25
€80.63
28.10.26
28.10.26
18.04%
20.02.26
20.02.26
